SPI1 and colorectal cancer: In colorectal cancer patients, Th9 cells and IL-9 promoted tumor growth, with both IL-9 and PU.1 elevated in intestinal mucosal tissues, and tumor growth inhibited in IL-9 or PU.1 knockout mouse models (50).